Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this Randomized, Double-blind, Multicenter, Two-period Crossover Study is to
Assess the Efficacy and Tolerability of Burlulipase (NM-BL) in Patients with Exocrine
Pancreatic Insufficiency due to Cystic Fibrosis